Puma Biotechnology Inc Capital Reinvestment Ratio
Puma Biotechnology Inc capital reinvestment ratio. Puma Biotechnology Inc (PBYI) has a Capital Reinvestment Ratio of 0.00x as of December 2025, meaning it reinvests 0% of its operating cash flow ($14.42 Million) in capital expenditures ($36.00K). See PBYI cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Puma Biotechnology Inc (2019–2025)
Capital reinvestment ratio of Puma Biotechnology Inc from 2019 to 2025. This chart tracks Puma Biotechnology Inc's Capital Reinvestment Ratio across 6 annual periods. See how financially flexible is Puma Biotechnology Inc to measure the company's free cash flow as a share of total liabilities.
Puma Biotechnology Inc Capital Reinvestment Ratio by Year (2019–2025)
Puma Biotechnology Inc capital reinvestment ratio by year from 2019 to 2025. For the full cash flow conversion analysis, see PBYI cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | $41.80 Million | $71.00K | ▲ +18.0% |
| 2024 | 0.00x | $38.92 Million | $56.00K | ▼ -99.7% |
| 2023 | 0.47x | $27.01 Million | $12.64 Million | ▲ +966303.8% |
| 2021 | 0.00x | $20.65 Million | $1.00K | ▼ -100.0% |
| 2020 | 25.06x | $800.00K | $20.05 Million | ▲ +183130.9% |
| 2019 | 0.01x | $22.38 Million | $306.00K | — |